Ambrisentan is an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension, where it works by selectively blocking endothelin A receptors to lower vascular resistance… Read more









![Chemical structure of 2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenyl propanoic acid ethyl ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-46-Dimethylpyrimidin-2-yloxy-3-methoxy-33-diphenyl-propanoic-acid-ethyl-ester.png&w=3840&q=75)






































Ambrisentan is an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension, where it works by selectively blocking endothelin A receptors to lower vascular resistance in the lungs. This collection provides essential reference standards for this therapeutic agent, including related impurities, metabolites, and stable isotope labelled compounds necessary for pharmaceutical research and quality control. Analytical laboratories utilize these materials to conduct accurate impurity profiling and validate methods during drug development and manufacturing. By incorporating pharmacopeial and non-pharmacopeial impurities, such as pyrimidine derivatives and hydroxy acid analogs, into analytical procedures, researchers can monitor degradation pathways—including hydrolysis and oxidation—to ensure product stability and safety. Furthermore, stable isotope labelled versions of the parent molecule and its metabolites serve as critical internal standards for precise quantification in pharmacokinetic studies and bioanalytical testing.